chr11-2884670-C-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_001122630.2(CDKN1C):c.787G>A(p.Asp263Asn) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000812 in 1,232,274 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001122630.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 8.12e-7 AC: 1AN: 1232274Hom.: 0 Cov.: 29 AF XY: 0.00000165 AC XY: 1AN XY: 607320
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Beckwith-Wiedemann syndrome Pathogenic:1
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 274 of the CDKN1C protein (p.Asp274Asn). This variant also falls at the last nucleotide of exon 1, which is part of the consensus splice site for this exon. For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Experimental studies have shown that this missense change affects CDKN1C function (PMID: 24098681). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 35531). This missense change has been observed in individual(s) with IMAGe syndrome (PMID: 22634751, 24313804). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). -
Inborn genetic diseases Pathogenic:1
The c.820G>A (p.D274N) alteration is located in exon 1 (coding exon 1) of the CDKN1C gene. This alteration results from a G to A substitution at nucleotide position 820, causing the aspartic acid (D) at amino acid position 274 to be replaced by an asparagine (N)._x000D_ _x000D_ Based on the available evidence, the CDKN1C c.820G>A (p.D274N) alteration is classified as pathogenic for IMAGE syndrome; however, this variant is unlikely to be causative of Beckwith-Wiedemann syndrome. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration has been observed in multiple unrelated individuals with IMAGE syndrome and has been reported as de novo and maternally inherited (Arboleda, 2012; Kato, 2014; Amano, 2017; Homma, 2019; Bolomiti, 2021). This amino acid position is well conserved in available vertebrate species with limited sequence alignment. This missense alteration is located in a region that has a low rate of benign missense variation (Lek, 2016; Firth, 2009). Functional assays modestly suggest that protein stability is increased, but additional evidence is needed to confirm these data (Hamajima, 2013). This alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. -
IMAGe syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at